Cargando…
Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
Autores principales: | Simmons, Aaron B., Bretz, Colin A., Wang, Haibo, Kunz, Eric, Hajj, Kassem, Kennedy, Carson, Yang, Zhihong, Suwanmanee, Thipparat, Kafri, Tal, Hartnett, M. Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208888/ https://www.ncbi.nlm.nih.gov/pubmed/29943214 http://dx.doi.org/10.1007/s10456-018-9626-5 |
Ejemplares similares
-
Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
por: Simmons, Aaron B., et al.
Publicado: (2018) -
Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms
por: Becker, Silke, et al.
Publicado: (2018) -
RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2022) -
Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery
por: Suwanmanee, Thipparat, et al.
Publicado: (2017) -
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.
por: Hu, Peirong, et al.
Publicado: (2018)